Group One Trading’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2078 |
|
|
2025
Q1 | – | Sell |
-5,362
| Closed | -$11.4K | – | 1990 |
|
|
2024
Q4 | $11.4K | Sell |
5,362
-10,800
| -67% | -$23K | ﹤0.01% | 1514 |
|
|
2024
Q3 | $45.3K | Buy |
16,162
+15,718
| +3,540% | +$44K | ﹤0.01% | 1029 |
|
|
2024
Q2 | $1.04K | Sell |
444
-58,480
| -99% | -$136K | ﹤0.01% | 1550 |
|
|
2024
Q1 | $263K | Buy |
58,924
+21,365
| +57% | +$95.5K | ﹤0.01% | 600 |
|
|
2023
Q4 | $121K | Sell |
37,559
-17,600
| -32% | -$56.5K | ﹤0.01% | 859 |
|
|
2023
Q3 | $175K | Buy |
55,159
+48,153
| +687% | +$153K | ﹤0.01% | 769 |
|
|
2023
Q2 | $34.8K | Sell |
7,006
-3,606
| -34% | -$17.9K | ﹤0.01% | 1098 |
|
|
2023
Q1 | $52.4K | Buy |
10,612
+10,324
| +3,585% | +$51K | ﹤0.01% | 996 |
|
|
2022
Q4 | $1.81K | Buy |
+288
| New | +$1.81K | ﹤0.01% | 1673 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1960 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1975 |
|
|
2022
Q1 | – | Sell |
-12,460
| Closed | -$186K | – | 2020 |
|
|
2021
Q4 | $186K | Buy |
12,460
+9,344
| +300% | +$139K | ﹤0.01% | 1230 |
|
|
2021
Q3 | $80K | Sell |
3,116
-1,434
| -32% | -$36.8K | ﹤0.01% | 1413 |
|
|
2021
Q2 | $119K | Sell |
4,550
-15,193
| -77% | -$397K | ﹤0.01% | 1281 |
|
|
2021
Q1 | $697K | Buy |
19,743
+18,830
| +2,062% | +$665K | ﹤0.01% | 657 |
|
|
2020
Q4 | $23K | Buy |
+913
| New | +$23K | ﹤0.01% | 1284 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1535 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1390 |
|
|
2020
Q1 | – | Sell |
-6,005
| Closed | -$156K | – | 1365 |
|
|
2019
Q4 | $156K | Buy |
6,005
+5,300
| +752% | +$138K | ﹤0.01% | 696 |
|
|
2019
Q3 | $19K | Sell |
705
-35
| -5% | -$943 | ﹤0.01% | 1014 |
|
|
2019
Q2 | $20K | Buy |
740
+500
| +208% | +$13.5K | ﹤0.01% | 949 |
|
|
2019
Q1 | $7K | Buy |
+240
| New | +$7K | ﹤0.01% | 1028 |
|